The growing preference for plant-based and naturally derived pharmaceuticals is fueling the expansion of the Natural APIs ...

"We would like to inform that the Company has completed the capacity expansion (Phase I) of the API plant at Pithampur," the ...

Brokerage firm Elara is positive on the shares of Aurobindo Pharma Limited. The broking firm said that the Kakinada plant could meet 80 per cent of India’s Penicillin-G requirement.

Pharmaceutical company, Merck is closing a Pennsylvania plant. Cherokee Pharmaceuticals, a wholly owned subsidiary of Merck Sharp & Dohme, which is a wholly owned subsidiary of Merck & Co., has filed ...

Researchers have discovered that Daphne pseudomezereum (commonly known as Onishibari) contains a substance inhibiting ...

With grant funding from governments at multiple levels in Canada, Entos Pharmaceuticals is looking to plant roots at a CAD ...

After getting its hands on a massive Quebecois manufacturing plant from Sandoz in 2022, French CDMO Delpharm is making good ...

Three of the new sites would produce active pharmaceutical ingredients for ... It expects the plants to be making medicines within five years.

The filing further read the company will provide a comprehensive response to US FDA for the observations within the ...

Tobacco, historically known for its harmful effects, may become the future of pharmaceutical production through genetic ...

Drugmaker AstraZeneca and British-based renewable energy firm Future Biogas have opened a plant to produce biogas from organic waste. The facility, located in Gonerby Moor, Lincolnshire ...